BackCytoMed Therapeutics Overview

CytoMed Therapeutics Cost of Revenue

Cost of Revenue analysis for GDTC.

Quarterly Cost of Revenue

$562801.00
↑ 973.74% YoY

As of Dec 31, 2025

Annual Cost of Revenue (TTM)

$629476.00
↑ 78.23% YoY

Trailing 12 months ending Dec 31, 2025

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin